Dicerna Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved inducement grants of stock options to purchase a total of 136,300 shares of common stock and 38,600 restricted stock units to be distributed among 17 new employees with a grant date of April 1, 2020.
April 1, 2020
· 3 min read